Company Filing History:
Years Active: 2019-2021
Title: Adriana Diaz-Quinones: Innovator in Cancer Research
Introduction
Adriana Diaz-Quinones is a prominent inventor based in West Lafayette, IN (US). She has made significant contributions to the field of cancer research, particularly in developing compounds that target specific receptors involved in cancer progression. With a total of 2 patents, her work is paving the way for potential clinical applications in oncology.
Latest Patents
Adriana's latest patents include a groundbreaking invention titled "Dock derived compound against laminin receptor (37 LR) and uses thereof." This patent describes an in silico screening method that generated compounds targeting the laminin receptor 37LR. The anti-cancer functions of these compounds have been tested in prostate cancer cell lines. Additionally, a group of derivatives based on the hit compound from the in silico screening has been synthesized and tested, showing improved IC values that could have relevant clinical use for prostate cancer or osteoarthritis.
Career Highlights
Adriana is affiliated with the Purdue Research Foundation, where she continues her innovative work in cancer research. Her dedication to advancing medical science is evident in her research and patent contributions.
Collaborations
Adriana collaborates with esteemed colleagues, including Marxa L Figueiredo and Charles Samuel Umbaugh. These partnerships enhance her research efforts and contribute to the development of effective cancer treatments.
Conclusion
Adriana Diaz-Quinones is a trailblazer in the field of cancer research, with her innovative patents and collaborations driving advancements in medical science. Her work holds promise for improving treatment options for patients with prostate cancer and osteoarthritis.